Advertisement

Topics

Latest "Demegen Incorporated" News Stories

21:17 EDT 24th May 2018 | BioPortfolio

Here are the most relevant search results for "Demegen Incorporated" found in our extensive news archives from over 250 global news sources.

More Information about Demegen Incorporated on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Demegen Incorporated for you to read. Along with our medical data and news we also list Demegen Incorporated Clinical Trials, which are updated daily. BioPortfolio also has a large database of Demegen Incorporated Companies for you to search.

Showing "Demegen Incorporated" News Articles 1–25 of 52

Thursday 24th May 2018

Independent Stent Imaging Study Shows Excellent Healing Profile with Resolute Onyx DES in Complex Patients with Coronary Artery Disease

Onyx 1-Month OCT Study Provides Potential Insights on DAPT Duration in Complex Patients Following Stent Implantation DUBLIN and PARIS- May 24, 2018 - Investigators today unveiled clinical data from the independently run Onyx 1-Month OCT Study, which showed strong early vessel healing in a patient population that contained a high percentage of patients with complex coronary artery dis...


Wednesday 16th May 2018

Herbalife Nutrition Announces the Adjusted Price Range of Its Dutch Auction Tender Offer for Common Shares Following Stock-Split

Herbalife Nutrition Ltd. (NYSE: HLF) (“Herbalife Nutrition” or “the Company”) announced today the adjusted price range of its tender offer for Herbalife Nutrition’s common shares, par value $0.0005 per share (“shares”), wherein the Company is seeking to purchase up to $600 million in shares. Following the adjustment to reflect the Company’s ...

Tuesday 8th May 2018

Ligand Reports First Quarter 2018 Financial Results

Conference Call Begins at 4:30 p.m. Eastern Time Today Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) today reported financial results for the three months ended March 31, 2018, and provided an operating forecast and program updates. Ligand management will host a conference call today beginning at 4:30 p.m. Eastern time to discuss this announcement...


Mannatech Reports First Quarter 2018 Financial Results

Mannatech, Incorporated (NASDAQ: MTEX), a global health and wellness company committed to transforming lives to make a better world, today announced financial results for its first quarter of 2018. First Quarter Results

Friday 4th May 2018

Nicox Provides First Quarter 2018 Business and Financial Results

Press Release Nicox Provides First Quarter 2018 Business  and Financial Results ..............................................   May 4, 2018 - release at 7:30 am CET Sophia Antipolis, France   Nicox SA (

Thursday 3rd May 2018

Teleflex Reports First Quarter 2018 Results

First Quarter Revenues of $587.2 million, up 20.4% Versus Prior Year Period; up 14.6% on Constant Currency Basis First Quarter GAAP Diluted EPS of $1.18, up 35.6% Over the Prior Year Period First Quarter Adjusted Diluted EPS of $2.15, up 19.4% Versus Prior Year Period Raised 2018 Guidance Range for GAAP Revenue Growth from...

Wednesday 2nd May 2018

HeartSciences Announces Professor Peter Macfarlane Joins Clinical Advisory Board

Southlake, Texas – May 2, 2018 – HeartSciences, a U.S.-based medical device company that is leading innovation in the field of electrocardiology through the application of continuous wavelet transform (CWT) signal processing and artificial intelligence, announced today that Peter W. Macfarlane has joined its board of clinical advisors.  Professor Peter W. Macfarlane, DSc eF...

Friday 27th April 2018

Herbalife Nutrition Announces Extension of Its Tender Offer for Common Shares

Herbalife Nutrition Ltd. (NYSE: HLF) (“Herbalife Nutrition” or “the Company”) announced today it is extending the expiration time of its previously announced tender offer from 5:00 P.M., New York City time, Wednesday, May 16, 2018, to 5:00 P.M., New York City time, Thursday, May 24, 2018, unless the tender offer is further extended. The te...

Teleflex Incorporated to Host Analyst & Investor Day on May 11, 2018

Teleflex Incorporated (NYSE: TFX), a leading global provider of medical devices, today announced the agenda for its 2018 Analyst & Investor Day, which will be held on Friday, May 11, 2018. A live webcast of the event presentations will begin at 9:00 a.m. ET. 2018 Analyst & Investor Day Agenda:8 a.m. Registration and Product Showcase9 a.m....

Tuesday 24th April 2018

Robert A. Essner, former Chairman and Chief Executive of Wyeth, named Executive Chairman of Elucida Oncology, Inc.

NEW YORK, NY--(Marketwired - April 25, 2018) - ELUCIDA ONCOLOGY, INC®, a biotechnology company focused on developing and commercializing a first-in-class, ultra-small nanoparticle platform technology for the diagnosis and treatment of cancer, announced today that it has appointed Robert A. Essner as its Executive Chairman. Mr. Essner was Chairman and Chief Executive Officer for Wyeth, acquired by...

Friday 20th April 2018

MDxHealth (R): SelectMDx Included in Dutch DRG Reimbursement System

NEWS RELEASE                                                                                          Further progress of strategy to expand market for SelectMDx® IRVINE, CA, and HERSTAL, BELGIUM - 07:00 CEST, April 20, 2018 - MDxHealth SA ("MDxHealth, or the "Company"), (Euronext: MDXH.BR), a world leader in molecular...

Thursday 19th April 2018

SpeeDx receives FDA clearance for Mycoplasma genitalium product

SYDNEY, Australia, April 19, 2018 (GLOBE NEWSWIRE) -- SpeeDx's ResistancePlus® MG Positive Control kit has now been listed with the US Food and Drug Administration (FDA) for sale in the United States through the company's recently incorporated US entity, SpeeDx Inc. The announcement coincides with the FDA registration of the Australian parent company - SpeeDx Pty Ltd - as a Medi...

Wednesday 18th April 2018

Herbalife Announces Self-Tender Offer Seeking to Purchase up to $600 Million of Its Common Shares

Herbalife Ltd. (NYSE: HLF) (“Herbalife” or “the Company”) announced today it has commenced a “modified Dutch auction” self-tender offer to purchase in cash up to an aggregate $600 million of shares of its common stock at a per share price not greater than $108.00 nor less than $98.00 (the “tender offer”). The closing price of Herb...

Tuesday 17th April 2018

AACR annual meeting 2018: Nanobiotix presented preclinical data showing NBTXR3 nanoparticles can activate the cGAS-STING pathway

  AACR ANNUAL MEETING 2018: NANOBIOTIX PRESENTED PRECLINICAL DATA SHOWING NBTXR3 NANOPARTICLES CAN ACTIVATE THE cGAS-STING PATHWAY Paris, France and Cambridge, Massachusetts, April 17, 2018 - NANOBIOTIX (Euronext: NANO - ISIN: FR0011341205), a late clinical-stage nanomedicine company pioneering new approaches to the local treatment of cancer, today announced that preclinical da...

Medtronic Expands Focus on Interventional Oncology with Its U.S. Launch of OptiSphere(TM) Embolization Spheres

Product Line Offers Unique, Resorbable Option for Patients with Hypervascular Tumors DUBLIN - April 17, 2018 - Medtronic plc (NYSE: MDT) today announced its U.S. launch of OptiSphere(TM) embolization spheres, a resorbable embolic platform designed for embolization of hypervascular tumors. OptiSphere offers patients an alternative treatment option, a resorbable embolic, with compar...

Novartis tender offer for AveXis commences

Novartis International AG / Novartis tender offer for AveXis commences . Processed and transmitted by Nasdaq Corporate Solutions. The issuer is solely responsible for the content of this announcement. Basel, April 17, 2018 - Novartis AG (NYSE: NVS) ("Novartis") today announced that its indirect wholly-owned subsidiary, Novartis AM Merger Corporation, a Delaware corporation...

Tuesday 10th April 2018

NANOBIOTIX : THE UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER AND NANOBIOTIX HAVE AN AGREEMENT TO RUN IMMUNOTHERAPEUTIC PRE-CLINICAL RESEARCH IN LUNG CANCER COMBINING NBTXR3 AND NIVOLUMAB

                                                                  THE UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER AND NANOBIOTIX HAVE AN AGREEMENT TO RUN IMMUNOTHERAPEUTIC PRE-CLINICAL RESEARCH IN LUNG CANCER COMBINING NBTXR3 AND NIVOLUMAB Paris, France and Cambridge, Massachusetts, USA, April 10, 2018 -

Thursday 5th April 2018

Congenica Ltd Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 27022018] Prices from USD $250

Summary   Congenica Ltd Congenica is a biotechnology company that offers clinical decision support software and services . The company's technology SAPIENTIA, is used to personalize patient care through accurate diagnoses and analysis of genomic data. It offers services such as variant interpretation and clinical reporting. The company's clinical reporting allows share access of...

Wednesday 4th April 2018

Relevium Targets 83 Million Unique Monthly Visitors and 26 Countries Through European Expansion of Bioganix(R)

MONTREAL, QUEBEC -- (Marketwired) -- 04/05/18 -- Relevium Technologies Inc. (TSX VENTURE: RLV)(OTCQB: RLLVF)(FRANKFURT: 6BX) (the "Company" or "Relevium"), is pleased to announce that it has started the process of establishing European presence for the new Bioganix® brand in partnership with several online partners, including Amazon. Management will be doing an initial launch of eight best selli...

Monday 2nd April 2018

Relevium Announces All-Time Record High of Units Sales for Bioganix(R) in March

MONTREAL, QUEBEC -- (Marketwired) -- 04/03/18 -- Relevium Technologies Inc. (TSX VENTURE: RLV)(OTCQB: RLLVF)(FRANKFURT: 6BX) (the "Company" or "Relevium"), is pleased to report an all-time record high in unit sales for the month of March 2018. The reported record high of 16,549 units, which was achieved in a seasonally low period, reflects increased online demand for the Bioganix® established p...

Wednesday 28th March 2018

Relevium Launches New Bioganix Brand Architecture

MONTREAL, QUEBEC -- (Marketwired) -- 03/29/18 -- Relevium Technologies Inc. (TSX VENTURE: RLV)(OTCQB: RLLVF)(FRANKFURT: 6BX) (the "Company" or "Relevium"), is pleased to announce it has completed the re-positioning of its Bioganix brand. The new re-positioning enhances Bioganix around the key branding points of Credibility, Quality and Trust. The Company will be rolling out its new brand and new ...

Mannatech Reports Fourth Quarter 2017 Financial Results

Mannatech, Incorporated (NASDAQ: MTEX), a global health and wellness company committed to transforming lives to make a better world, today announced financial results for its fourth quarter of 2017. Quarter End Results Fourth quarter net

Friday 23rd March 2018

Publication of the annual report and invitation to the annual shareholders' meeting

Mechelen, Belgium; 23 March 2018, 21.30 CET; regulated information - Galapagos NV (Euronext & NASDAQ: GLPG) published its annual report for the financial year 2017. The annual report for the financial year 2017, including a review of figures and performance, is available online at http://reports.glpg.com/annual-report-2017/en/ and can also be downloaded as PDF. Furthermore, ...

New Real-World Clinical Practice Data Reinforces the Value of the Oncotype DX Breast Recurrence Score® Test for Patients, Physicians and the Health Care System

Further demonstrate the test’s ability to impact treatment decisions with an overall reduction in chemotherapy use and underscore the value of broader access for patients Geneva, Switzerland, March 23, 2018 / B3C newswire / -- Genomic Health today announced the presentation of new data with the Oncotype DX® test at the 11th European Breast Cancer Conference (EBCC-11) in Barcelona,...

Monday 19th March 2018

Addex Shareholders Approved all Board Proposals at Extraordinary General Meeting

Addex Therapeutics / Addex Shareholders Approved all Board Proposals at Extraordinary General Meeting . Processed and transmitted by Nasdaq Corporate Solutions. The issuer is solely responsible for the content of this announcement. Geneva, Switzerland, 19 March 2018 - Addex Therapeutics (SIX: ADXN), the leading developer of oral allosteric modulators for neurological disorders, an...


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks